de Langen, A. J., Jebbink, M., Hashemi, S. M. S., Kuiper, J. L., de Bruin-Visser, J., Monkhorst, K., . . . Smit, E. F. (2018). Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment. Br J Cancer.

de Langen, Adrianus J., M. Jebbink, Sayed M. S. Hashemi, Justine L. Kuiper, J. de Bruin-Visser, Kim Monkhorst, Erik Thunnissen, a Egbert F. Smit. "Trastuzumab and Paclitaxel in Patients With EGFR Mutated NSCLC That Express HER2 After Progression On EGFR TKI Treatment." Br J Cancer 2018.

de Langen, Adrianus J., et al. "Trastuzumab and Paclitaxel in Patients With EGFR Mutated NSCLC That Express HER2 After Progression On EGFR TKI Treatment." Br J Cancer 2018.